TMC Innovation

We had an amazing time at the Texas Life Science Forum today.

The Texas Life Science Forum is the premier life science event in Texas that brings together members from industry, emerging life science companies, academic, and investors. The 10th Annual conference was held today at Rice University and we were able to meet investors, learn about promising life science companies and hear about opportunities for entrepreneurs, investment professionals, big pharma, academics, and business executives serving the life science industry.

To find out more about The Texas Life Science Forum, click the link below.
https://txlifescienceforum.org/

Rice Alliance for Technology & Entrepreneurship

Hurry and apply for Texas Medical Center's Accelerator for health tech TODAY!

Applications close on January 31st!

http://ow.ly/QqLw50Hf60w

Our Accelerator for focuses on refining clinical value propositions to improve healthcare delivery and outcomes.

Apply by January 30th to join an outstanding portfolio of life science founders: https://bit.ly/3JIr9CM

Interested in our Accelerator for health tech?

Register today for one of our info sessions!

January 6th 8:00AM CST: http://ow.ly/zZoa50Hf74H

January 6th 4:00PM CST: https://us06web.zoom.us/meeting/register/tZcsc-2orTosGNFrkEPpv-ljSEC8vnMXxBxH

We are excited to announce our Spring 2022 cohort for our Accelerator for health tech!

Exciting news! Applications are now open for Texas Medical Center Innovation's Accelerator for health tech. Learn more and APPLY here! - http://ow.ly/muXI50Heo8w

"Houston is a place where everyone looks at when it comes to novel research and approaches to treating cancer. The landscape here is going to be accelerated because we see much more collaboration between the founding institutions — and that's a very important element of growth. Houston has no comparison to any other place in terms of what's going on here and the level and quality of research," shares Enrique Gomez, Accelerator for Cancer Therapeutics Entrepreneur-in-Residence on the Houston Innovators Podcast.

Listen to the podcast here: http://ow.ly/Kzx050HiivG

Thank you Natalie Harms and InnovationMap

How Houston is emerging as a leader for oncology innovation, according to this expert Houston is currently establishing itself as a hub for health care innovation — and Enrique Gomez should know. He's worked in the field of biopharmaceuticals across the continent.

"I am drawn to the challenges in the healthcare industry and the opportunity to work with other talented innovators from diverse backgrounds to quickly bring breakthrough products to market. That’s why I ended up applying.”
-Odero Otieno, Biodesign Founder, TMC Innovation

The is accepting applications for the next cohort of Founders until January 1, 2022. Learn more about the program and apply today!

https://bit.ly/3DN0rp5

“I’ve been immersed in Houston’s life science commercialization ecosystem for years and have worked with academicians, clinicians, and biotech companies. Driven by mitigating the gaps that can develop between the research lab and delivery of patient care makes TMCi Biodesign a perfect fit for me. The program creates a pathway to really understand a need, and provides the resources to see your solution through to the end.”
-Meagan Pitcher Ph.D., CLP, Biodesign Founder, TMC Innovation

The is accepting applications for the next cohort of Founders until January 1, 2022. Learn more about the program and apply today! https://bit.ly/3DN0rp5

"At TMC Innovation, our mission is to increase the quality and quantity of density in Houston.

We achieve this through facilitating collaboration between promising innovators and entrepreneurs with the best minds our member institutions have to offer. Through one of our 3 programs in biodesign, health tech, and cancer therapeutics, we form, foster, recruit and fund healthcare companies from around the globe to create the future of healthcare.

Learn more about TMCi and our programs. http://ow.ly/cgqh50Hcmbb

At TMC Innovation, we facilitate the growth and commercialization of innovative health tech ideas by removing the barriers facing startups.

Our latest blog talks about our unique positioning as the innovation branch of the and how we work to support life science entrepreneurs by providing accessibility, strategic efficiency, and inclusivity during clinical trials.

Read learn more about our mentorship and development programs: http://ow.ly/nuFQ50HclVU

“I had the engineering and ER background, and I was getting this itch to do something more. In the ER, I was solving problems using what I already had, so I was never able to create something new, or at least improve on something we already had. TMCi Biodesign tied in my engineering experience, what I was learning about business and the medical aspect all in one.” -Britt Cross, Physician, Biodesign Founder, TMC Innovation

The is accepting applications for the next cohort of Founders until January 1, 2022. Learn more about the program and apply today!

https://bit.ly/3DN0rp5

The is a 10-month, full-time paid program for MD’s, PH.D.’s, MBA’s, technology specialists and engineers who want to contribute to healthcare innovation. In our latest blog, we highlight several founders who successfully launched their businesses through our program and have gone on with great momentum.

Read more about their success stories and how you can apply for the next cohort: http://ow.ly/1aTx50HaLnf

Apply here by January 1st: http://ow.ly/vwcR50HaLnj

Recently on an episode of MIDI’s “The Innovation Vault” Tom Luby, Director, was featured to discuss eHealth ventures. Tom gives insight into the industry and about relocating to Houston with JLABs – a science incubator and lab accelerator tab for biotech - before stepping into his role at TMC Innovation.

Take a listen to the podcast here: http://ow.ly/G5ch30s3WrO

Houston’s health ecosystem is expanding rapidly and companies are looking well beyond the healthcare industry in search of leaders with the right mix of experience and perspective. Read more on our blog.

https://www.tmc.edu/innovation/news/

“120,000 professionals come to work every day at the . There are billions of dollars in NIH and other grant funding that flows into each of the member institutions, and several universities located in and around the medical center. Mix all that together, plus a dash of the general spirit of entrepreneurship that takes place in Texas - and in Houston specifically - and it comes out that there are a lot of people thinking about how to commercialize much of the thinking and intellectual property here at the medical center.”

Listen to more innovation insights from Head of Innovation at TMC, Tom Luby, Ph.D.

http://ow.ly/lvzr50H12Rr

Jonathan Gunn is the Chief Executive Officer of Briteseed a company that develops technologies that detect critical tissues during minimally invasive surgeries.
Briteseed participated in the 2016 for Health Tech with a vision to create smart surgical tools that assist surgeons.

Access to business, technology, research, and investor resources is why life science founders want to be a part of our portfolio.
Visit our site today to learn more about our founders and to see which of our programs is the best fit for your company’s goals.

http://ow.ly/WEwN50GUyLb

The TMCi Accelerator for guides Texas-based biotech entrepreneurs and researchers contemplating career transitions via institutional technology transfer teams.

Funded by the Cancer Prevention and Research Institute of Texas (CPRIT), this accelerator leverages collaborations with the Gulf Coast Consortia (GCC) and the University of Texas Medical Branch (UTMB) to support participants along critical stages of their company’s growth in route to entering the marketplace.

Learn more about and our participating companies by visiting our site: http://ow.ly/a8r450GTAcV

Do you know the three primary diligence considerations healthcare investors are interested in?

The first is cost. Who pays for this solution to be used in health systems?

The second is use. When this technology is implemented into health systems, will patients, clinicians, or administrators be the primary users?

The third is evidence. How strong is the body of evidence that this solution offers enough value to see market success? When a startup can confidently and adequately address these questions, the chances of a successful entry into the market increase exponentially.

Read more of “3 Diligence Considerations for Healthcare Investors:” http://ow.ly/2pa250GR7H7

“I’ve been immersed in Houston’s life science commercialization ecosystem for years and have worked with academicians, clinicians, and biotech companies. I am driven by mitigating the gaps that can develop between the research lab and delivery of patient care. TMCi’s Biodesign program creates the pathway to really understand a need, and provides the resources to see your solution through to the end.” -Meagan Pitcher Ph.D., CLP, Biodesign Founder,

Learn more about the TMC Biodesign program and how you can become a part of it.

http://ow.ly/AVY150GPZ4E

Last week we were honored to host the Investor Meetings at . We offer a range of space options for life science companies that would like to be a part of the community.

Contact us today to learn more about our offerings.
http://ow.ly/iZ5u50GP6iM.

The intersection of healthcare and artificial intelligence (AI) holds potentials, unlike any other innovation the medical industry has seen before. The Director of Texas Medical Center Innovation, Tom Luby, shares his thoughts with the Ken Kennedy Institute, read more: http://ow.ly/IEs450GMtq7

The Intersection of Healthcare and Artificial Intelligence The intersection of healthcare and artificial intelligence (AI) holds potentials, unlike any other innovation the medical industry has seen before. AI’s ability to operate and automate tasks at heightened speed, efficiency, and accuracy have already made an impact on day-to-day hospital care and a...

Texas Medical Center Innovation is proud to be a part of Ignite Healthcare Network’s 5th annual mini-accelerator program!
Every year, the Ignite pitch competition highlights emerging women-led companies. On November 4th, selected startups will have the opportunity to pitch their in competition for investment prizes before an audience of healthcare executives and investors.

Are you registered? Leave us a comment if you’ll be joining us on January 20th

https://ignitehealthcare.org/fire-pitch-2021/

Fire Pitch 2021 - Ignite Health This contact intensive program connects female entrepreneurs leading healthcare start-ups with their potential customers and investors to assess and advise on the strengths and weaknesses of their companies. The result – direct feedback, connections to industry experts, as well as, pilots and inve...

For Sarah Gray, Founding Clinician of Trusted Health, nurses are more than a commodity.

The alum heads up a digital platform that matches nurses with trusted clinicians while giving them the freedom to explore the country and gain new experiences.
This is just one of many companies that have participated in a accelerator gaining access to business, technology, research, and investor resources.

For more information about Trusted Health click the link below.
http://ow.ly/Rru050GJRYK

Learn about our three programs for biodesign, health tech, and cancer therapeutics here: http://ow.ly/RVou50GJS5U

We would like to thank the Houston Food Bank for allowing to show its commitment to our community this past weekend. It is always an honor to volunteer in service to this special city, and our team was truly pleased to have been involved.
We look forward to future services opportunities as we continue to our mission to keep Houston healthy by cultivating a community of talented life science innovators.

Congratulations to TMCi Accelerator for Cancer Therapeutics Founder, Laurent Audoly and the Parthenon Therapeutics team for raising $65M!

This successful collaboration with Dr. Zhiqiang An on the PRTH-101 project is backed in part by local VC partners KdT Ventures.

We look forward to cheering on your continued success and supporting your growing ties here in Texas!

Read more: http://ow.ly/ln6Z50GJSXl

Interested in learning more about TMCi Accelerators? Visit here: http://ow.ly/Flh650GJSXk

Parthenon Therapeutics Raises $65 Million in Series A Funding to Advance Oncology Programs Aimed at Reprogramming the Tumor Microenvironment Parthenon Therapeutics, a biotech company inventing a novel class of anti-cancer therapies that reprogram the tumor microenvironment, today announced

The for Health Tech is thrilled to be kicking off another boot camp with a new cohort of promising, innovative organizations. From November 9th - 19th participating groups will be matched with and members, and network with mentors and stakeholders who will advise them on clinical and business strategies.

Sign up for our newsletter to keep an eye on this year’s promising organizations and to learn more about how you can get involved.

http://ow.ly/JTn050GJGNs

The Summit highlights the TMCi Accelerator for cancer therapeutics inaugural 2021 cohort and provides the opportunity for the Texas cancer research community to network and collaborate.

For more information, click the link below!
https://www.tmc.edu/innovation/accelerator-cancer/